Table 2.
Main outcomes of the in vivo studies on UA toxicity.
| Pramyothin et al. [27] | Wistar albino rats | 50 or 200 mg/kg for 5 days | No changes in transaminase level |
| Mitochondria and ER damage with the highest dose of UA | |||
|
| |||
| Joseph et al. [37] | B6C3F mice | 0, 60, 180, and 600 ppm for 2 weeks | Induction of genes associated with complexes I through IV of the electron transport chain |
| Overexpression of genes associated with fatty acid oxidation, Krebs cycle, apoptosis, and membrane transporters | |||
|
| |||
| Lu et al. [38] | Wistar rats | 100, 200, and 240 mg/kg for 8 days | Increased liver/body weight ratio |
| Signs of diffuse hepatocyte degeneration with the highest doses of UA | |||
| Changes in energy, amino acid, lipid, and nucleotide metabolism | |||
|
| |||
| Liu et al. [39] | Wistar rats | 100 and 240 mg/kg for 10 days | Changes in expression of proteins related to oxidative stress and lipid metabolism |
|
| |||
| Moreira et al. [40] | Wistar rats | Infusion of liver with solutions 1, 2.5, 5 and 10 μM at an infusion rate of 10 μL/min | Increase of oxygen consumption, decrease of ATP level, and inhibition of gluconeogenesis at lower UA concentration |
| Inhibition of mitochondrial electron flow and medium-chain fatty acid oxidation at highest UA concentrations | |||